InvestorsHub Logo
Followers 33
Posts 2863
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Saturday, 06/15/2024 7:48:38 PM

Saturday, June 15, 2024 7:48:38 PM

Post# of 161
Looking at HbF levels, EDIT-301 appears to achieve slightly higher levels than Casgevy. For total Hb levels, EDIT-301 seems to outperform Casgevy https://finance.yahoo.com/news/editas-medicine-announces-safety-efficacy-070000921.html

However, the ongoing trials and launch are going to be costly, and they aren't working on busulfan free conditioning.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EDIT News